Albany, CA, United States of America

Dmitry M Guschin

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.9

ph-index = 5

Forward Citations = 168(Granted Patents)


Location History:

  • Richmond, CA (US) (2015)
  • Albany, CA (US) (2013 - 2016)
  • Seoul, KR (2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Dmitry M Guschin: Innovator in Genomic Modification

Introduction

Dmitry M Guschin is a prominent inventor based in Albany, CA (US). He has made significant contributions to the field of genomic modification, holding a total of 5 patents. His work focuses on innovative methods for targeted integration of genetic material, which has implications for various applications in biotechnology.

Latest Patents

One of his latest patents is titled "Targeted genomic modification with partially single-stranded donor molecules." This patent discloses donor molecules that comprise single-stranded complementary regions flanking one or more sequences of interest. These donor molecules and the compositions that include them can be utilized in methods for the targeted integration of an exogenous sequence into a specified region of interest in the genome of a cell. This innovative approach enhances the precision of genomic modifications, paving the way for advancements in genetic engineering.

Career Highlights

Dmitry has worked with notable companies in the biotechnology sector, including Sangamo Biosciences, Inc. and Sangamo Therapeutics, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Gregory J Cost and Fyodor Urnov. Their collaborative efforts have furthered the understanding and application of genomic technologies.

Conclusion

Dmitry M Guschin's work in genomic modification exemplifies the innovative spirit of modern science. His patents and collaborations highlight the importance of targeted genetic engineering in advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…